Update on pathology of inflammatory myopathy
Authors:
- 7 January 2025
- journal article
- Published by Wiley in Clinical and Experimental Neuroimmunology
- Vol. 16 (1) , 55-63
Abstract
Inflammatory myopathy is classified into primary autoimmune myositis and secondary myositis due to various factors, such as drugs and autoimmune connective tissue diseases. Autoimmune myositis mainly consists of dermatomyositis, antisynthetase syndrome‐associated myositis, immune‐mediated necrotizing myopathy, and inclusion body myositis. This review aims to provide insights into muscle pathology for clinical practice and an understanding of pathophysiology in inflammatory myopathy by summarizing current knowledge about the pathology of each subform of autoimmune myositis and some secondary myositis. Dermatomyositis is associated with type I interferon upregulation. Expression of myxovirus resistance protein A (a type I interferon‐induced protein) in myofibers is utilized as a sensitive diagnostic marker. Antisynthetase syndrome‐associated myositis is morphologically characterized by perifascicular necrosis. A recent study suggests the presence of a characteristic immunological micromilieu suitable for plasma cells in the skeletal muscle tissue. Immune‐mediated necrotizing myopathy features an active necrotic and regenerating process. In inclusion body myositis, inflammatory cellular infiltration and rimmed vacuoles reflecting autophagy disruption are observed. The lymphocytes invading myofibers are composed of a highly differentiated T‐cell population, which is considered a potential therapeutic target.Keywords
This publication has 58 references indexed in Scilit:
- Clinicopathological and circulating cell‐free DNA profile in myositis associated with anti‐mitochondrial antibodyAnnals of Clinical and Translational Neurology, 2023
- Clinical utility of anti‐cytosolic 5’‐nucleotidase 1A antibody in idiopathic inflammatory myopathiesAnnals of Clinical and Translational Neurology, 2021
- Skeletal Muscle Involvement in Antisynthetase SyndromeJAMA Neurology, 2017
- Pathomechanisms of anti–cytosolic 5′‐nucleotidase 1A autoantibodies in sporadic inclusion body myositisAnnals of Neurology, 2017
- Pathogenic role of anti–signal recognition protein and anti–3‐Hydroxy‐3‐methylglutaryl‐CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathiesAnnals of Neurology, 2017
- Cytosolic 5′‐nucleotidase 1A autoimmunity in sporadic inclusion body myositisAnnals of Neurology, 2012
- Autoantibodies to cytosolic 5′‐nucleotidase 1A in inclusion body myositisAnnals of Neurology, 2012
- Interferon‐stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophyAnnals of Neurology, 2010
- Molecular pathology and pathogenesis of inclusion‐body myositisMicroscopy Research and Technique, 2005
- Interferon‐α/β–mediated innate immune mechanisms in dermatomyositisAnnals of Neurology, 2005